Hydroxychloroquine for respiratory distress syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Mar 2020: Trial registered, NCT04308668
  2. 17 Mar 2020: Trial started, NCT04308668

The trials

NCT04308668: Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

State
Completed
Phase
Phase 3
People
1,312 taking part
Started
17 Mar 2020
Primary completion
20 May 2020
Arms
Treatment
Results
Posted on the registry
  1. 16 Mar 2020: Trial registered
  2. 17 Mar 2020: Trial started
  3. 20 May 2020: Trial completed
  4. 13 May 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Hydroxychloroquine (HCQ), Hydroxychloroquine Oral Product, Hydroxychloroquine Sulfate 200 MG [Plaquenil], Hydroxychloroquine Sulfate Tablets, Polirreumin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.